Nephros, Inc.
NEPH
$2.90
$0.124.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.67% | 32.36% | 21.16% | 10.34% | -0.53% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.67% | 32.36% | 21.16% | 10.34% | -0.53% |
| Cost of Revenue | 31.72% | 24.90% | 12.01% | 4.39% | -6.75% |
| Gross Profit | 33.27% | 37.13% | 27.17% | 14.26% | 3.78% |
| SG&A Expenses | 17.25% | 4.15% | -6.75% | -12.78% | -13.86% |
| Depreciation & Amortization | 3.70% | -6.58% | -17.92% | -26.94% | -36.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.63% | 13.64% | 1.37% | -5.18% | -10.58% |
| Operating Income | 19,000.00% | 250.52% | 197.66% | 151.92% | 100.38% |
| Income Before Tax | 1,255.06% | 262.33% | 204.40% | 156.75% | 105.65% |
| Income Tax Expenses | -20.00% | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,513.51% | 259.42% | 202.55% | 155.70% | 104.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,513.51% | 259.42% | 202.55% | 155.70% | 104.70% |
| EBIT | 19,000.00% | 250.52% | 197.66% | 151.92% | 100.38% |
| EBITDA | 798.60% | 296.65% | 223.89% | 170.77% | 110.37% |
| EPS Basic | 1,531.88% | 257.90% | 201.70% | 154.82% | 104.55% |
| Normalized Basic EPS | 1,292.16% | 260.36% | 203.37% | 155.74% | 105.38% |
| EPS Diluted | 21,060.00% | 240.11% | 191.01% | 148.82% | 100.32% |
| Normalized Diluted EPS | 1,268.63% | 258.38% | 202.98% | 155.74% | 105.38% |
| Average Basic Shares Outstanding | 0.86% | 0.76% | 0.79% | 1.07% | 1.33% |
| Average Diluted Shares Outstanding | 3.62% | 2.25% | 1.44% | 1.23% | 1.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |